Search research articles
Contact Us
Filters
Showing results (61-70 of 196) with videos related to
Page
of 20
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine
|
September 5, 2013
Enhanced dopamine release by mesenchymal stem cells reprogrammed neuronally by the modulators of SMAD signaling, chromatin modifying enzymes, and cyclic adenosine monophosphate levels
Ryan T Funk, Arshak R Alexanian
European Journal of Haematology. Supplementum
|
January 1, 1989
Chemotherapy for resistant and relapsing multiple myeloma
R Alexanian, B Barlogie, G Ventura
American Journal of Hematology
|
December 1, 1985
Beta 2 microglobulin in multiple myeloma
R Alexanian, B Barlogie, H Fritsche
Experimental Neurology
|
December 14, 2004
Quiescent neural cells regain multipotent stem cell characteristics influenced by adult neural stem cells in co-culture
Arshak R Alexanian, Shekar N Kurpad
Archives of Internal Medicine
|
November 1, 1984
Amyloidosis in multiple myeloma or without apparent cause
R Alexanian, G Fraschini, L Smith
The New England Journal of Medicine
|
May 24, 1984
Effective treatment of advanced multiple myeloma refractory to alkylating agents
B Barlogie, L Smith, R Alexanian
Analytical and Quantitative Cytology and Histology
|
May 1, 1987
Characterization of hematologic malignancies by flow cytometry
B Barlogie, P McLaughlin, R Alexanian
The American Journal of Medicine
|
May 1, 1986
Biclonal and hypodiploid multiple myeloma
L Smith, B Barlogie, R Alexanian
Annals of Internal Medicine
|
July 1, 1986
High-dose glucocorticoid treatment of resistant myeloma
R Alexanian, B Barlogie, D Dixon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Primary therapy of Waldenstrom's macroglobulinemia with paclitaxel
M A Dimopoulos, R Luckett, R Alexanian
Page
of 20
Search research articles
Search
Showing results (61-70 of 196) with videos related to
Sort By:
Page
of 20
Translational Research : the Journal of Laboratory and Clinical Medicine
|
September 5, 2013
Enhanced dopamine release by mesenchymal stem cells reprogrammed neuronally by the modulators of SMAD signaling, chromatin modifying enzymes, and cyclic adenosine monophosphate levels
Ryan T Funk, Arshak R Alexanian
European Journal of Haematology. Supplementum
|
January 1, 1989
Chemotherapy for resistant and relapsing multiple myeloma
R Alexanian, B Barlogie, G Ventura
American Journal of Hematology
|
December 1, 1985
Beta 2 microglobulin in multiple myeloma
R Alexanian, B Barlogie, H Fritsche
Experimental Neurology
|
December 14, 2004
Quiescent neural cells regain multipotent stem cell characteristics influenced by adult neural stem cells in co-culture
Arshak R Alexanian, Shekar N Kurpad
Archives of Internal Medicine
|
November 1, 1984
Amyloidosis in multiple myeloma or without apparent cause
R Alexanian, G Fraschini, L Smith
The New England Journal of Medicine
|
May 24, 1984
Effective treatment of advanced multiple myeloma refractory to alkylating agents
B Barlogie, L Smith, R Alexanian
Analytical and Quantitative Cytology and Histology
|
May 1, 1987
Characterization of hematologic malignancies by flow cytometry
B Barlogie, P McLaughlin, R Alexanian
The American Journal of Medicine
|
May 1, 1986
Biclonal and hypodiploid multiple myeloma
L Smith, B Barlogie, R Alexanian
Annals of Internal Medicine
|
July 1, 1986
High-dose glucocorticoid treatment of resistant myeloma
R Alexanian, B Barlogie, D Dixon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Primary therapy of Waldenstrom's macroglobulinemia with paclitaxel
M A Dimopoulos, R Luckett, R Alexanian
Page
of 20